Discovery of ginisortamab, a potent and novel anti-gremlin-1 antibody in clinical development for the treatment of cancer

References

• Kosinski C, Li VS, Chan AS, Zhang J, Ho C, Tsui WY, Chan TL, Mifflin RC, Powell DW, Yuen ST, et al. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc Natl Acad Sci U S A. 2007;104(39):15418–14. doi:10.1073/pnas.0707210104.
   PubMed Web of Science ®Google Scholar
• Katagiri T, Watabe T. Bone morphogenetic proteins. Cold Spring Harb Perspect Biol. 2016;8(6):a021899. doi:10.1101/cshperspect.a021899.
   PubMed Web of Science ®Google Scholar
• Mulloy B, Rider CC. The bone morphogenetic proteins and their antagonists. Vitam Horm. 2015;99:63–90.
   PubMed Web of Science ®Google Scholar
• Brazil DP, Church RH, Surae S, Godson C, Martin F. BMP signalling: agony and antagony in the family. Trends Cell Biol. 2015;25(5):249–64. doi:10.1016/j.tcb.2014.12.004.
   PubMed Web of Science ®Google Scholar
• Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell. 1998;1(5):673–83. doi:10.1016/S1097-2765(00)80067-2.
   PubMed Web of Science ®Google Scholar
• Kattamuri C, Luedeke DM, Nolan K, Rankin SA, Greis KD, Zorn AM, Thompson TB. Members of the DAN family are BMP antagonists that form highly stable noncovalent dimers. J Mol Biol. 2012;424(5):313–27. doi:10.1016/j.jmb.2012.10.003.
   PubMed Web of Science ®Google Scholar
• Khokha MK, Hsu D, Brunet LJ, Dionne MS, Harland RM. Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning. Nat Genet. 2003;34(3):303–07. doi:10.1038/ng1178.
   PubMed Web of Science ®Google Scholar
• Nilsson EE, Larsen G, Skinner MK. Roles of Gremlin1 and Gremlin 2 in regulating ovarian primordial to primary follicle transition. Reproduction. 2014;147(6):865–74. doi:10.1530/REP-14-0005.
   PubMed Web of Science ®Google Scholar
• Jindal S, Greenseid K, Berger D, Santoro N, Pal L. Impaired gremlin 1 (GREM1) expression in cumulus cells in young women with diminished ovarian reserve (DOR). J Assist Reprod Genet. 2012;29(2):159–62. doi:10.1007/s10815-011-9684-8.
   PubMed Web of Science ®Google Scholar
• Lopez Navarro E, Ortega FJ, Francisco-Busquets E, Sabater-Masdeu M, Alvarez-Castano E, Ricart W, Fernandez-Real JM. Thyroid hormone receptors are differentially expressed in granulosa and cervical cells of infertile women. Thyroid. 2016;26(3):466–73. doi:10.1089/thy.2015.0416.
   PubMed Web of Science ®Google Scholar
• Kattamuri C, Nolan K, Thompson TB. Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif. Biochem J. 2017;474(7):1093–107. doi:10.1042/BCJ20161050.
   PubMedGoogle Scholar
• Nolan K, Kattamuri C, Luedeke DM, Angerman EB, Rankin SA, Stevens ML, Zorn AM, Thompson TB. Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists. J Biol Chem. 2015;290(8):4759–71. doi:10.1074/jbc.M114.628412.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Y, Hou R, Shu Z. Knockdown GREM1 suppresses cell growth, angiogenesis, and epithelial-mesenchymal transition in colon cancer. J Cell Biochem. 2019;120(4):5583–96. doi:10.1002/jcb.27842.
   PubMed Web of Science ®Google Scholar
• Sun Z, Cai S, Liu C, Cui Y, Ji J, Jiang WG, Ye L. Increased expression of gremlin1 promotes proliferation and epithelial mesenchymal transition in gastric cancer cells and correlates with poor pognosis of patients with gastric cancer. Cancer Genomics Proteomics. 2020;17(1):49–60. doi:10.21873/cgp.20167.
   PubMed Web of Science ®Google Scholar
• Hong D, Liu T, Huang W, Liao Y, Wang L, Zhang Z, Chen H, Zhang X, Xiang Q. Gremlin1 delivered by mesenchymal stromal cells promoted epithelial-mesenchymal transition in human esophageal squamous cell carcinoma. Cell Physiol Biochem. 2018;47(5):1785–99. doi:10.1159/000491060.
   PubMedGoogle Scholar
• Elemam NM, Malek AI, Mahmoud EE, El-Huneidi W, Talaat IM. Insights into the role of gremlin-1, a bone morphogenic protein antagonist, in cancer initiation and progression. Biomedicines. 2022;10(2):301. doi:10.3390/biomedicines10020301.
   PubMed Web of Science ®Google Scholar
• Ren J, Smid M, Iaria J, Salvatori DCF, van Dam H, Zhu HJ, Martens JWM, Ten Dijke P. Cancer-associated fibroblast-derived gremlin 1 promotes breast cancer progression. Breast Cancer Res. 2019;21(1):109. doi:10.1186/s13058-019-1194-0.
   PubMed Web of Science ®Google Scholar
• Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, West R, Gladstone H, Chang HY, Morganroth GS, Oro AE, et al. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A. 2006;103(40):14842–47. doi:10.1073/pnas.0606857103.
   PubMed Web of Science ®Google Scholar
• Jaeger E, Leedham S, Lewis A, Segditsas S, Becker M, Cuadrado PR, Davis H, Kaur K, Heinimann K, Howarth K, et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet. 2012;44(6):699–703. doi:10.1038/ng.2263.
   PubMed Web of Science ®Google Scholar
• Whitelaw SC, Murday VA, Tomlinson IP, Thomas HJ, Cottrell S, Ginsberg A, Bukofzer S, Hodgson SV, Skudowitz RB, Jass JR, et al. Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology. 1997;112(2):327–34. doi:10.1053/gast.1997.v112.pm9024286.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247.
   PubMed Web of Science ®Google Scholar
• Ciuclan L, Sheppard K, Dong L, Sutton D, Duggan N, Hussey M, Simmons J, Morrell NW, Jarai G, Edwards M, et al. Treatment with anti–gremlin 1 antibody ameliorates chronic Hypoxia/SU5416–induced pulmonary arterial hypertension in mice. Am J Pathol. 2013;183(5):1461–1473. doi:10.1016/j.ajpath.2013.07.017.
   PubMed Web of Science ®Google Scholar
• Cheng C, Wang J, Xu P, Zhang K, Xin Z, Zhao H, Ji Z, Zhang M, Wang D, He Y, et al. Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer. Nat Cancer. 2022;3(5):565–80. doi:10.1038/s43018-022-00380-3.
   PubMedGoogle Scholar
• Clark KC, Hewett DR, Panagopoulos V, Plakhova N, Opperman KS, Bradey AL, Mrozik KM, Vandyke K, Mukherjee S, Davies GCG, et al. Targeted disruption of bone marrow stromal cell-derived gremlin1 limits multiple myeloma disease progression in vivo. Cancers Basel. 2020;12(8):2149. doi:10.3390/cancers12082149.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Gieniec KA, Wright JA, Wang T, Asai N, Mizutani Y, Lida T, Ando R, Suzuki N, Lannagan TRM, et al. The balance of stromal BMP signaling mediated by GREM1 and ISLR drives colorectal carcinogenesis. Gastroenterology. 2021;160(4):1224–1239.e30. doi:10.1053/j.gastro.2020.11.011.
   PubMed Web of Science ®Google Scholar
• Bruhns P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood. 2012;119(24):5640–49. doi:10.1182/blood-2012-01-380121.
   PubMed Web of Science ®Google Scholar
• Kisonaite M, Wang X, Hyvonen M. Structure of gremlin-1 and analysis of its interaction with BMP-2. Biochem J. 2016;473(11):1593–604. doi:10.1042/BCJ20160254.
   PubMedGoogle Scholar
• Nolan K, Kattamuri C, Luedeke DM, Deng X, Jagpal A, Zhang F, Linhardt RJ, Kenny AP, Zorn AM, Thompson TB. Structure of protein related to Dan and Cerberus: insights into the mechanism of bone morphogenetic protein antagonism. Structure. 2013;21(8):1417–29. doi:10.1016/j.str.2013.06.005.
   PubMed Web of Science ®Google Scholar
• Nolan K, Kattamuri C, Rankin SA, Read RJ, Zorn AM, Thompson TB. Structure of gremlin-2 in complex with GDF5 gives insight into DAN-family-mediated BMP antagonism. Cell Rep. 2016;16(8):2077–86. doi:10.1016/j.celrep.2016.07.046.
   PubMed Web of Science ®Google Scholar
• Hinck AP, Mueller TD, Springer TA. Structural biology and evolution of the TGF-β family. Cold Spring Harb Perspect Biol. 2016;8(12):a022103. doi:10.1101/cshperspect.a022103.
   PubMed Web of Science ®Google Scholar
• Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet. 2009;41(4):478–81. doi:10.1038/ng.320.
   PubMed Web of Science ®Google Scholar
• Yadin D, Knaus P, Mueller TD. Structural insights into BMP receptors: specificity, activation and inhibition. Cytokine Growth Factor Rev. 2016;27:13–34. doi:10.1016/j.cytogfr.2015.11.005.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–22. doi:10.1016/j.ccr.2012.02.022.
   PubMed Web of Science ®Google Scholar
• Dutton LR, Hoare OP, McCorry AMB, Redmond KL, Adam NE, Canamara S, Bingham V, Mullan PB, Lawler M, Dunne PD, et al. Fibroblast-derived gremlin1 localises to epithelial cells at the base of the intestinal crypt. Oncotarget. 2019;10(45):4630–39. doi:10.18632/oncotarget.27050.
   PubMedGoogle Scholar
• Qi Z, Li Y, Zhao B, Xu C, Liu Y, Li H, Zhang B, Wang X, Yang X, Xie W, et al. BMP restricts stemness of intestinal Lgr5(+) stem cells by directly suppressing their signature genes. Nat Commun. 2017;8(1):13824. doi:10.1038/ncomms13824.
   PubMedGoogle Scholar
• Sato M, Kawana K, Fujimoto A, Yoshida M, Nakamura H, Nishida H, Inoue T, Taguchi A, Takahashi J, Adachi K, et al. Clinical significance of gremlin 1 in cervical cancer and its effects on cancer stem cell maintenance. Oncol Rep. 2016;35(1):391–97. doi:10.3892/or.2015.4367.
   PubMed Web of Science ®Google Scholar
• Yan K, Wu Q, Yan DH, Lee CH, Rahim N, Tritschler I, DeVecchio J, Kalady MF, Hjelmeland AB, Rich JN. Glioma cancer stem cells secrete gremlin1 to promote their maintenance within the tumor hierarchy. Genes Dev. 2014;28(10):1085–100. doi:10.1101/gad.235515.113.
   PubMed Web of Science ®Google Scholar
• Civenni G, Walter A, Kobert N, Mihic-Probst D, Zipser M, Belloni B, Seifert B, Moch H, Dummer R, van den Broek M, et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res. 2011;71(8):3098–109. doi:10.1158/0008-5472.CAN-10-3997.
   PubMed Web of Science ®Google Scholar
• Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer. 2006;5(1):67. doi:10.1186/1476-4598-5-67.
   PubMedGoogle Scholar
• Barbato L, Bocchetti M, Di Biase A, Regad T. Cancer stem cells and targeting strategies. Cells. 2019;8(8):926. doi:10.3390/cells8080926.
   PubMed Web of Science ®Google Scholar
• Holdsworth G, Bon H, Bergin M, Qureshi O, Paveley R, Atkinson J, Huang L, Tewari R, Twomey B, Johnson T. Publisher correction: quantitative and organisational changes in mature extracellular matrix revealed through high-content imaging of total protein fluorescently stained in situ. Sci Rep. 2017;7(1):18111. doi:10.1038/s41598-017-16513-z.
   PubMedGoogle Scholar
• Kabsch W. Xds. Acta Crystallogr D Biol Crystallogr. 2010;66(2):125–32. doi:10.1107/S0907444909047337.
   PubMedGoogle Scholar
• McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. J Appl Crystallogr. 2007;40:658–674. doi:10.1107/S0021889807021206.
   PubMed Web of Science ®Google Scholar
• Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of coot. Acta Crystallogr D Biol Crystallogr. 2010;66(4):486–501. doi:10.1107/S0907444910007493.
   PubMedGoogle Scholar
• Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F, Vagin AA. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr. 2011;67(4):355–67. doi:10.1107/S0907444911001314.
   PubMedGoogle Scholar
• Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66(2):213–21. doi:10.1107/S0907444909052925.
   PubMedGoogle Scholar
• Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr. 2010;66(1):12–21. doi:10.1107/S0907444909042073.
   PubMedGoogle Scholar